Structure-activity relationships for organometallic osmium arene phenylazopyridine complexes with potent anticancer activity.
about
Mirror-image organometallic osmium arene iminopyridine halido complexes exhibit similar potent anticancer activity.Potent organo-osmium compound shifts metabolism in epithelial ovarian cancer cells.Organometallic Iridium(III) anticancer complexes with new mechanisms of action: NCI-60 screening, mitochondrial targeting, and apoptosis.Dicarba-closo-dodecarborane-containing half-sandwich complexes of ruthenium, osmium, rhodium and iridium: biological relevance and synthetic strategies.Fast and slow versus strong and weak metal-DNA binding: consequences for anti-cancer activity.The contrasting catalytic efficiency and cancer cell antiproliferative activity of stereoselective organoruthenium transfer hydrogenation catalysts.Anticancer Organometallic Osmium(II)-p-cymene Complexes.Potent organometallic osmium compounds induce mitochondria-mediated apoptosis and S-phase cell cycle arrest in A549 non-small cell lung cancer cells.Bidentate ligands on osmium(VI) nitrido complexes control intracellular targeting and cell death pathways.Ruthenium- and osmium-arene complexes of 8-substituted indolo[3,2-c]quinolines: Synthesis, X-ray diffraction structures, spectroscopic properties, and antiproliferative activity.Antimalarial activity of ruthenium(II) and osmium(II) arene complexes with mono- and bidentate chloroquine analogue ligands.Halide Control of N,N-Coordination versus N,C-Cyclometalation and Stereospecific Phenyl Ring Deuteration of Osmium(II) p-Cymene Phenylazobenzothiazole Complexes.Pharmaco-genomic investigations of organo-iridium anticancer complexes reveal novel mechanism of action.Designing organometallic compounds for catalysis and therapy.Anti-Inflammatory Oxicams as Multi-donor Ligand Systems: pH- and Solvent-Dependent Coordination Modes of Meloxicam and Piroxicam to Ru and Os.Structure-activity relationships for ruthenium and osmium anticancer agents - towards clinical development.The Anticancer Activities of Some Nitrogen Donor Ligands Containing bis-Pyrazole, Bipyridine, and Phenanthroline Moiety Using Docking Methods.The contrasting chemical reactivity of potent isoelectronic iminopyridine and azopyridine osmium(ii) arene anticancer complexesSynthesis, Characterization, and Biological Properties of Osmium-Based Tamoxifen Derivatives - Comparison with Their Homologues in the Iron and Ruthenium SeriesOsmium(vi) nitrido complexes bearing azole heterocycles: a new class of antitumor agentsOrganometallic chemistryThe Spectroscopic and Conductive Properties of Ru(II) Complexes with Potential Anticancer Properties
P2860
Q34795234-A6F2C756-6F83-406E-A04C-87881C4422B7Q35895492-22BC9E5C-2554-473A-9C23-BFF557574F19Q36952837-80713EDB-4D76-4985-8105-FC07EA5F2737Q37981543-E39E6169-3F42-452B-A14D-2BDBD3D051D9Q38001300-A21B49D4-1F84-4B64-9A5C-1B979FD3BB26Q38775808-2C89893A-A714-44E7-9910-A6EBDB07E8A4Q38851401-47A7DDC0-511C-4C62-A4F3-45FAC53C4F29Q39011794-E3244B93-2EE9-4FEE-8CCC-82CE093CEA8AQ39095158-B7DC5182-ECBE-4392-9C6B-8EF10D75E293Q41642755-C761DB7D-048A-4788-AB09-10FAE46AB930Q41916555-5836909F-7FFB-4D36-A7A7-8C726AA4FBBFQ46237975-CEC1A428-A117-417E-B31E-0BFF0D71C724Q46262834-8C349B16-FEB7-4648-9C79-A7CE4E404E45Q48007506-863509B7-D657-47F3-A417-5AB81D12C841Q48235861-556CDF9B-9D2A-471B-8949-5F7BD9F3E8C2Q49687144-6C4739BC-0F5F-4D60-A1C8-13AB6A0D2391Q55394029-51D9D1DB-7449-45FC-8F64-4B71F4945673Q56058410-6851BCC5-FBA6-46F2-AFCF-DDCEB21B9C08Q57391513-A5CF12FB-E58B-40FA-A919-26D33F353E02Q58214102-2B674D14-7FB8-447E-A51C-7F98178BCD7CQ58864522-3EC01F93-77F4-430E-A35E-139898D1CA8AQ59062348-81487FA8-5B22-4D1E-BF66-9070E8081ABA
P2860
Structure-activity relationships for organometallic osmium arene phenylazopyridine complexes with potent anticancer activity.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Structure-activity relationshi ...... th potent anticancer activity.
@en
Structure-activity relationshi ...... th potent anticancer activity.
@nl
type
label
Structure-activity relationshi ...... th potent anticancer activity.
@en
Structure-activity relationshi ...... th potent anticancer activity.
@nl
prefLabel
Structure-activity relationshi ...... th potent anticancer activity.
@en
Structure-activity relationshi ...... th potent anticancer activity.
@nl
P2093
P2860
P356
P1433
P1476
Structure-activity relationshi ...... th potent anticancer activity.
@en
P2093
Aida M B H Basri
Darren Braddick
Guy J Clarkson
Peter J Sadler
P2860
P304
10553-10562
P356
10.1039/C1DT10937E
P407
P577
2011-08-22T00:00:00Z